Lbp Am Sa decreased its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 8.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 280,934 shares of the industrial products company's stock after selling 26,116 shares during the period. Lbp Am Sa owned 0.12% of Xylem worth $36,342,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Wealth Enhancement Advisory Services LLC boosted its holdings in Xylem by 8.4% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 52,401 shares of the industrial products company's stock valued at $6,080,000 after purchasing an additional 4,052 shares during the period. GAMMA Investing LLC boosted its holdings in Xylem by 15,322.5% in the 1st quarter. GAMMA Investing LLC now owns 506,630 shares of the industrial products company's stock valued at $60,522,000 after purchasing an additional 503,345 shares during the period. Fifth Third Wealth Advisors LLC boosted its holdings in Xylem by 5.4% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,206 shares of the industrial products company's stock valued at $264,000 after purchasing an additional 113 shares during the period. Rhumbline Advisers boosted its holdings in Xylem by 6.4% in the 1st quarter. Rhumbline Advisers now owns 450,736 shares of the industrial products company's stock valued at $53,845,000 after purchasing an additional 27,046 shares during the period. Finally, Czech National Bank boosted its holdings in Xylem by 5.9% in the 1st quarter. Czech National Bank now owns 55,800 shares of the industrial products company's stock valued at $6,666,000 after purchasing an additional 3,124 shares during the period. Institutional investors own 87.96% of the company's stock.
Insider Transactions at Xylem
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business's stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at $413,861.72. The trade was a 25.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.27% of the stock is currently owned by corporate insiders.
Xylem Price Performance
XYL stock opened at $147.72 on Wednesday. The company has a 50 day simple moving average of $140.93 and a 200 day simple moving average of $128.91. The stock has a market cap of $35.96 billion, a price-to-earnings ratio of 38.37, a P/E/G ratio of 2.49 and a beta of 1.09. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $147.95. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. The business had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Research analysts anticipate that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date was Thursday, August 28th. Xylem's dividend payout ratio is currently 41.56%.
Analysts Set New Price Targets
A number of analysts have issued reports on the stock. Mizuho boosted their price objective on shares of Xylem from $125.00 to $140.00 and gave the company a "neutral" rating in a report on Friday, September 12th. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. TD Cowen boosted their price objective on shares of Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a report on Tuesday, August 26th. Cowen restated a "hold" rating on shares of Xylem in a research report on Tuesday, August 26th. Finally, Stifel Nicolaus boosted their target price on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research report on Friday, August 1st. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $152.33.
Check Out Our Latest Stock Report on Xylem
Xylem Company Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report